Professional Documents
Culture Documents
US Research Quarterly Equity 2022 04 26 SIFMA PDF
US Research Quarterly Equity 2022 04 26 SIFMA PDF
The SIFMA Research Quarterlies contain data and statistics on U.S. markets. The equity and related report –
cash equites, ETFs, listed options and capital formation – includes information on: volumes, volatility, total
equity issuance, IPOs, market shares, exchange landscapes, etc.
All reports, including the two fixed income quarterlies (issuance and trading; outstanding), and corresponding
databases can be found at: www.sifma.org/research
Contents
Executive Summary ................................................................................................................................................................................... 4
Quarterly Highlights .................................................................................................................................................................................... 5
Chart Book: US Equity Capital Formation .................................................................................................................................................. 6
IPO Issuance and Other Statistics.............................................................................................................................................................. 6
Chart Book: US Cash Equities ................................................................................................................................................................. 11
Volumes and Other Statistics ................................................................................................................................................................... 11
Exchange and Parent Group Market Share.............................................................................................................................................. 18
Chart Book: US Multi-Listed Options ........................................................................................................................................................ 19
Volumes and Other Statistics ................................................................................................................................................................... 19
Exchange and Parent Group Market Share.............................................................................................................................................. 21
Chart Book: US Exchange-Traded Funds ................................................................................................................................................ 22
Volumes and Other Statistics ................................................................................................................................................................... 22
Exchange and Provider Market Share ...................................................................................................................................................... 24
Appendix: Exchange Landscape .............................................................................................................................................................. 25
Cash Equities ........................................................................................................................................................................................... 25
Multi-Listed Options .................................................................................................................................................................................. 26
Appendix: Terms to Know ........................................................................................................................................................................ 27
Authors ..................................................................................................................................................................................................... 30
Associated Reports
Please also see SIFMA Research Quarterly Reports: US Fixed Income – Issuance & Trading, US Fixed Income – Outstanding
and US Financial Institutions – Financial & Regulatory Data, which can be found at: https://www.sifma.org/ research
SIFMA Insights Primers: The SIFMA Insights primer series is a reference tool that goes beyond a typical 101 series. By
illustrating important technical and regulatory nuances, SIFMA Insights primers provide a fundamental understanding of the
marketplace and set the scene to address complex issues arising in today’s markets. The SIFMA Insights market structure
primer series includes: Global Capital Markets & Financial Institutions; Primary, Secondary & Post-Trade Markets; Electronic
Trading; U.S. Fixed Income; SOFR, the Transition from LIBOR; U.S. Equity; U.S. Multi-Listed Options; U.S. ETFs; U.S. Capital
Formation and Listings Exchanges; and Evolution of the Fintech Narrative. The primers and other Insights reports can be found
at: https://www.sifma.org/primers
SIFMA is the leading trade association for broker-dealers, investment banks and asset managers operating in the U.S. and global capital markets. On
behalf of our industry's one million employees, we advocate on legislation, regulation and business policy affecting retail and institutional investors,
equity and fixed income markets and related products and services. We serve as an industry coordinating body to promote fair and orderly markets,
informed regulatory compliance, and efficient market operations and resiliency. We also provide a forum for industry policy and professional
development. SIFMA, with offices in New York and Washington, D.C., is the U.S. regional member of the Global Financial Markets Association (GFMA).
For more information, visit http://www.sifma.org.
This report is subject to the Terms of Use applicable to SIFMA’s website, available at http://www.sifma.org/legal. Copyright © 2022
Executive Summary
The U.S. equity markets are the largest in the world and continue to be among the deepest, most liquid and most
efficient, representing 41.6% of the $117 trillion global equity market cap, or $49 trillion. This is 3.8x the next largest
market, China. U.S. market share has averaged 37.4% over the last 10 years, troughing at 32.9% in 2012 and
peaking at 42.0% in 2021.
Other DM
9.6%
Singapore
Other EM
0.6%
9.6%
Australia
1.7% US
Canada 41.6%
2.9%
UK
3.1%
Hong
Kong
4.3% Japan EU27
5.1% 10.6% China
10.9%
100 88 90
73 77
80 70 72
67
57
60 52 49
42
32 30 34
40 27
24 26 25
19
20
0
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 YTD
Source: World Federation of Exchanges, SIFMA estimates
Note: YTD data is preliminary
Quarterly Highlights
In this report, we recap statistics for U.S. primary and secondary markets, including cash equities, multi-listed
options, ETFs, and capital formation (IPOs, total issuance). The report also includes various market metrics, such as
volatility, index prices, etc.
The S&P 500 index averaged 4,463.86 for the quarter and 4,391.27 for March, 1Q22 +15.5% Y/Y (peak 4,796.56,
trough 4,170.70). The DJIA averaged 34,679.48 and 34,029.74, 1Q22 +9.9% Y/Y (peak 36,799.65, trough
32,632.64). The Nasdaq averaged 14,000.62 and 13,623.26, 1Q22 +4.9% Y/Y (peak 15,832.80, trough 12,581.22).
And the Russell 2000 averaged 2,055.89 and 2,036.85, 1Q22 -6.5% Y/Y (peak 2,272.56, trough 1,931.29). The VIX
averaged 25.37 for the quarter and 26.97 for March, 1Q22 -27.2% Y/Y (peak 36.45, trough 16.60).
ADVs were up Y/Y for ETFs and options but down for equity. Equity ADV was 12.9B shares for the quarter, -12.1%
Y/Y (peak 19.2B, trough 10.1B). ETF ADV was 2.9B shares for the quarter, +47.9% Y/Y (peak 5.3B, trough 2.0B).
Options ADV was 42.5M contracts for the quarter, +1.2% Y/Y (peak 63.0M, trough 33.8M).
For capital formation, total equity issuance was $28.9B for the quarter (-79.7% Y/Y) and the total IPO issuance was
$2.3 (-94.5% Y/Y). The number of IPOs was down 75.8% Y/Y. Private equity deal value increased 1.3% Y/Y.
1Q22 4Q21 1Q21 Y/Y Q/Q 2022 YTD 2021 YTD Y/Y
Primary Markets
Total Equity Issuance ($B) 28.9 90.1 142.3 -79.7% -67.9% 28.9 142.3 -79.7%
Total IPO Value ($B) 2.3 35.8 43.0 -94.5% -93.4% 2.3 43.0 -94.5%
# IPOs 24 84 99 -75.8% -71.4% 24 99 -75.8%
Small Cap as % Total IPOs 96% 80% 64% 32.2% 16.1% 96% 64% 32.2%
# Listed Companies 4,854 4,805 4,343 11.8% 1.0% 4,734 4,771 -0.8%
Private Equity Deal Value ($B) 222.2 328.7 219.3 1.3% -32.4% 222.2 219.3 1.3%
Secondary Markets
Equity ADV (B) 12.9 10.8 14.7 -12.1% 19.5% 12.9 14.7 -12.1%
ETF ADV (B) 2.9 1.8 1.9 47.9% 56.9% 2.9 1.9 47.9%
ETFs as % Equitiy ADV 22.2% 16.9% 13.2% 9.0% 5.3% 22.2% 13.2% 9.0%
Options ADV (M) 42.5 40.8 42.0 1.2% 4.1% 10.4 10.1 3.2%
Market Performance (Price)
S&P 500 4,463.86 4,602.11 3,865.71 15.5% -3.0% 4,463.86 3,865.71 15.5%
DJIA 34,679.48 35,517.11 31,550.58 9.9% -2.4% 34,679.48 31,550.58 9.9%
Nasdaq 14,000.62 15,390.79 13,351.46 4.9% -9.0% 14,000.62 13,351.46 4.9%
Russell 2000 2,055.89 2,276.63 2,198.73 -6.5% -9.7% 2,055.89 2,198.73 -6.5%
VIX 25.37 19.28 23.20 9.4% 31.6% 25.37 23.20 9.4%
Source: Bloomberg, Cboe Global Markets, Dealogic, Options Clearing Corporation, World Federation of Exchanges, SIFMA estimates
Note: IPO data Includes rank eligible deals; excludes BDCs, SPACs, ETFs, CLEFs & rights offers; 1Q22 number of listed companies is preliminary;
1Q22 and 4Q21 private equity deal value data are preliminary
Total Equity Issuance by Type ($B) Total Equity Issuance by Type (# Deals)
IPOs Secondary Offerings Preferred Stock IPOs Secondary Offerings Preferred Stock
500 1,600
436 1,391
450 1,400
390 101
400 58 1,157
47 1,200
350 972 85
1,000 916 886
300 90
225 46
250 220 222 228 800 82 897
26 17 34 258
200 600 863
728 685
150 653
155 155 145 400
100 9
154 29 200 126
50 4 393
85 209
39 50 49 154 185 151 93
0 22 0
FY17 FY18 FY19 FY20 FY21 YTD 2 FY17 FY18 FY19 FY20 FY21 YTD 24
6,500 6,274
6,000
5,620
5,500 5,162
3,500
FY00 FY01 FY02 FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 YTD
Source: Dealogic, World Federation of Exchanges, SIFMA estimates
Note: Includes rank eligible deals; excludes BDCs, SPACs, ETFs, CLEFs & rights offers. YTD number of listed companies is preliminary
Source: Dealogic
Note: IPOs include rank eligible deals; excludes BDCs, SPACs, ETFs, CLEFs and rights offers. Large cap = market cap $10B+; mid cap = market cap
$2B-$10B; small cap = market cap <$2B (mega cap >$200B, micro cap <$300M, nano cap <$50M)
0
FY00 FY01 FY02 FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 YTD
SPAC Deals
Volume ($B) # Deals (RHS)
200 613 650
600
175 162.6 550
150 500
450
125 400
248
350
100
83.3 300
75 250
200
50 150
66 34 46 59 54
28 37 17 10 12 20 13 100
25 1 12 12.1 1 7 16 9 10.0 10.8 13.6 9.9
0.02 0.5 2.1 3.4 3.8 0.04 0.5 1.1 0.5 1.4 1.7 3.9 3.5 50
0 0
FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 YTD
30
26 25
25
20 18 18 18
17
15 15
14 1313
15 12 11 13 12 13 12
11 11
1010 9 10
10 8 7
6 6 7 7
5 5 5 5
3 2 3 3 4 3
5 3 2 1 2 2 3 2
1 1 1 1
0.3 0.1
0
Jan-20
Jun-20
Jul-20
Jan-21
Jun-21
Jul-21
Jan-22
Feb-20
Mar-20
Feb-21
Mar-21
Feb-22
Mar-22
Aug-20
Sep-20
Nov-20
Dec-20
Aug-21
Sep-21
Nov-21
Dec-21
Apr-20
May-20
Oct-20
Apr-21
May-21
Oct-21
Source: Dealogic
Note: SPAC = special purpose acquisition company; a company with no commercial operations (shell company) established solely to raise capital
through an IPO for the purpose of acquiring unspecified existing companies; commonly referred to as blank check companies. IPOs include rank eligible
deals; excludes BDCs, SPACs, ETFs, CLEFs and rights offers
Jun-20
Jul-20
Jan-21
Jun-21
Jul-21
Jan-22
Feb-20
Mar-20
Feb-21
Mar-21
Feb-22
Mar-22
Aug-20
Sep-20
Nov-20
Dec-20
Aug-21
Sep-21
Nov-21
Dec-21
Apr-20
May-20
Oct-20
Apr-21
May-21
Oct-21
Quarterly Equity ADV
ADV (B shares) Trendline
16 14.7
14 12.9
12.4
12 11.0 10.8
10.5 10.6
9.9 9.8
10
8.5
7.6 7.5
8 6.8 6.9 6.9 6.9 6.9 6.8
6.1 6.4 6.3
6
0
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
3Q18
4Q18
1Q19
2Q19
3Q19
4Q19
1Q20
2Q20
3Q20
4Q20
1Q21
2Q21
3Q21
4Q21
1Q22
14 12.9
12.4
12 11.0 10.6 10.8
10.5 6.8
9.9 9.8
10 4.3 5.2
8.5 3.3
7.6 7.5
8 6.8 6.9 6.9 6.9 6.9 6.8 4.0 4.4 4.6 4.9
6.1 6.4 6.3 2.5 4.3
2.3 2.5 2.3 2.4
6 2.3 2.7
1.9 2.0 2.1 2.2 2.0 2.1
1.8 1.9 2.1 1.9 1.7 1.6 1.6 1.8
1.5 1.4 1.6
4 1.4 1.3 1.1 1.2 1.3 1.4 1.2
1.0 1.1
5.2 5.7 5.4 5.0
2 3.8 4.1 3.8 4.2 4.5 4.3 3.9 4.1
3.6 3.6 3.2 3.3 3.5 3.1 3.5 3.5 3.5
0
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
3Q18
4Q18
1Q19
2Q19
3Q19
4Q19
1Q20
2Q20
3Q20
4Q20
1Q21
2Q21
3Q21
4Q21
1Q22
Annual Equity ADV
ADV (B shares) Trendline
14 12.9
12 11.4
10.9
9.8
10 8.8 8.5
7.8
8 7.3 7.3 7.0
6.9 6.5
6.4 6.2 6.4
6
0
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
YTD
Source: Cboe Global Markets, SIFMA estimates
Note: Tape A – NYSE-listed; Tape B – all else (mostly NYSE Arca and American, also a main tape for ETF trading); Tape C – Nasdaq-listed
0 0
Jan-20
Jun-20
Jul-20
Jan-21
Jun-21
Jul-21
Jan-22
Feb-20
Mar-20
Feb-21
Mar-21
Feb-22
Mar-22
Aug-20
Sep-20
Nov-20
Dec-20
Aug-21
Sep-21
Nov-21
Dec-21
Apr-20
May-20
Oct-20
Apr-21
May-21
Oct-21
Monthly Volatility
VIX (Price) Trendline
65
60 57.7
55
50
45 41.5
40
35 30.9 31.1
27.7 29.4
30 26.8 25.0 24.9 23.1 25.8 27.0
25 19.6
22.9 22.4 21.8
19.8 19.8 21.4 23.2
20 17.4 17.0 17.6 17.5 17.9 18.5
13.9
15
10
5
0
Jan-20
Jun-20
Jul-20
Jan-21
Jun-21
Jul-21
Jan-22
Feb-20
Mar-20
Feb-21
Mar-21
Feb-22
Mar-22
Aug-20
Sep-20
Nov-20
Dec-20
Aug-21
Sep-21
Nov-21
Dec-21
Apr-20
May-20
Oct-20
Apr-21
May-21
Oct-21
Quarterly Volatility
VIX (Price) Trendline 34.5
35
31.2
30
25.8 25.6 25.4
25 23.2
21.1
19.3
20 17.4 18.0 18.3
16.5 16.0
15.3 15.2
14.0
15 12.9
11.7 11.4 10.9 10.3
10
0
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
3Q18
4Q18
1Q19
2Q19
3Q19
4Q19
1Q20
2Q20
3Q20
4Q20
1Q21
2Q21
3Q21
4Q21
1Q22
Annual Volatility
VIX (Price) Trendline
40
35 32.7
31.5
29.3
30 27.3
25.7 25.3
23.3 24.2
25 22.0 22.5
19.7
20 17.5 17.8
16.7 15.8 16.6
15.5 15.4
14.2 14.2
15 12.8 12.8
11.1
10
0
FY00
FY01
FY02
FY03
FY04
FY05
FY06
FY07
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
YTD
Source: Bloomberg, Cboe Global Markets, SIFMA estimates
Monthly Index Performance: S&P 500 Quarterly Index Performance: S&P 500
Price Trendline Price Trendline
5,000 4,675 5,000
4,602
4,500 4,500
4,141
4,464
4,391 4,000
4,000
3,500
3,366
3,500 3,177 2,850
3,000
2,902
3,000 2,790 2,932
2,500
Jun-17
Jan-19
Jun-19
Mar-20
Mar-22
Nov-17
Aug-18
Aug-20
Dec-20
Apr-18
Oct-19
May-21
Oct-21
1Q12
3Q12
1Q13
3Q13
1Q14
3Q14
1Q15
3Q15
1Q16
3Q16
1Q17
3Q17
1Q18
3Q18
1Q19
3Q19
1Q20
3Q20
1Q21
3Q21
1Q22
Monthly Index Performance: DJIA Quarterly Index Performance: DJIA
Price Trendline Price Trendline
40,000 40,500
35,641 35,517
35,000 35,500
Jun-17
Jan-19
Jun-19
Mar-20
Mar-22
Nov-17
Aug-18
Aug-20
Dec-20
Apr-18
Oct-19
May-21
Oct-21
1Q12
3Q12
1Q13
3Q13
1Q14
3Q14
1Q15
3Q15
1Q16
3Q16
1Q17
3Q17
1Q18
3Q18
1Q19
3Q19
1Q20
3Q20
1Q21
3Q21
1Q22
Source: Bloomberg
Jun-17
Jan-19
Jun-19
Mar-20
Mar-22
Nov-17
Aug-18
Aug-20
Dec-20
Apr-18
Oct-19
May-21
Oct-21
1Q12
3Q12
1Q13
3Q13
1Q14
3Q14
1Q15
3Q15
1Q16
3Q16
1Q17
3Q17
1Q18
3Q18
1Q19
3Q19
1Q20
3Q20
1Q21
3Q21
1Q22
Monthly Index Performance: Russell 2000 Quarterly Index Performance: Russell 2000
Price Trendline Price Trendline
2,500 2,362 2,500
2,237 2,277
2,250 2,300
2,100
2,000
1,712 1,667 2,037 1,900 2,056
1,698
1,750 1,589
1,504 1,700
1,500 1,500
1,547 1,518 1,256
1,250 1,388 1,393 1,300 1,162 1,416
1,203 1,320
1,000 1,100
900 1,041
750
700 821
500
500
Jan-17
Jun-17
Jan-19
Jun-19
Mar-20
Mar-22
Nov-17
Aug-18
Aug-20
Dec-20
Apr-18
Oct-19
May-21
Oct-21
1Q12
3Q12
1Q13
3Q13
1Q14
3Q14
1Q15
3Q15
1Q16
3Q16
1Q17
3Q17
1Q18
3Q18
1Q19
3Q19
1Q20
3Q20
1Q21
3Q21
1Q22
Source: Bloomberg
S&P 500 Average P/E Ratio S&P 500 Average P/E Ratio by Sector
35
31.4 Real Estate 49.1
29.4 Consumer Discretionary
30 34.6
25.5 25.3 Information Technology 30.1
25 22.9
21.2 21.2 21.7 Industrials 28.0
20.3 19.5 20.1
20 18.1 Aggregate 22.9
Consumer Staples 22.4
15
Utilities 21.3
10 Communication Services 20.5
Health Care 19.8
5
Materials 17.4
0 Energy 16.6
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
3Q18
4Q18
1Q19
2Q19
3Q19
4Q19
1Q20
2Q20
3Q20
4Q20
1Q21
2Q21
3Q21
4Q21
1Q22
Financials 13.5
S&P 500 Sector Breakdown Total Equity Market Short Interest (B shares)
24
Information Technology 28.0% 22.8
23 22.5
Health Care 13.6%
22 21.4
21.2 21.1 21.2
Consumer Discretionary 12.0%
21 20.5 20.7 20.7 20.7
20.3 20.3 20.4
Financials 11.1%
20 19.7
19.4
Communication Services 9.4%
19
Industrials 7.9%
18
Consumer Staples 6.1%
Energy 3.9% 17
Utilities 2.7% 16
NYSE 9.7%
MEMX 4.1%
Quarterly Parent Company Market Share
IEX 2.6%
Jun-20
Jul-20
Jan-21
Jun-21
Jul-21
Jan-22
Feb-20
Mar-20
Feb-21
Mar-21
Feb-22
Mar-22
Aug-20
Sep-20
Nov-20
Dec-20
Aug-21
Sep-21
Nov-21
Dec-21
Apr-20
May-20
Oct-20
Apr-21
May-21
Oct-21
Quarterly Listed Options ADV
ADV (M contracts) Trendline
45 42.0 42.5
40.8
40 36.4 37.5
35 32.2
29.5
30 28.0 28.2
25 22.4 22.5
18.8 19.2 19.3 19.8 19.5
20 17.3 18.3
16.6 16.7 16.2
15
10
5
0
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
3Q18
4Q18
1Q19
2Q19
3Q19
4Q19
1Q20
2Q20
3Q20
4Q20
1Q21
2Q21
3Q21
4Q21
1Q22
FY08
FY09
FY10
FY11
FY12
FY13
FY14
FY15
FY16
FY17
FY18
FY19
FY20
FY21
YTD
Monthly Listed Options ADV vs. Volatility
ADV (M contracts) VIX (Price, RHS)
50 70
44.1 45.0 44.6
45 42.2 40.8
57.7 39.4 38.6 60
39.1 38.4
40 36.4
31.8 34.3 33.9
35 41.5 31.3 50
30.1 29.1 28.8
30 27.1
24.5 40
25 31.1 29.4
25.8 27.0 30
20
30.9
22.9 22.4 23.1
19.8 19.8 21.4 23.2
15 26.8 27.7 17.4 17.6
25.0 24.9 20
21.8
10 19.6 18.5
17.0 17.5 10
5 13.9
0 0
Jan-20
Jun-20
Jul-20
Jan-21
Jun-21
Jul-21
Jan-22
Feb-20
Mar-20
Feb-21
Mar-21
Feb-22
Mar-22
Aug-20
Sep-20
Nov-20
Dec-20
Aug-21
Sep-21
Nov-21
Dec-21
Apr-20
May-20
Oct-20
Apr-21
May-21
Oct-21
93% 92.0%
87% 88.1%
Equity
94.3%
85%
FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 YTD
Cboe 15.0%
Nasdaq 7.9%
Cboe C2 3.7%
1.0
0.5
0.0
Jan-20
Jun-20
Jul-20
Jan-21
Jun-21
Jul-21
Jan-22
Feb-20
Mar-20
Feb-21
Mar-21
Feb-22
Mar-22
Aug-20
Sep-20
Nov-20
Dec-20
Aug-21
Sep-21
Nov-21
Dec-21
Apr-20
May-20
Oct-20
Apr-21
May-21
Oct-21
Quarterly ETF ADV
ADV (B shares) Trendline
3.5
3.0 2.9
2.6
2.5 2.3
2.0 1.9
2.0 1.8
1.5 1.6
1.5 1.5 1.5 1.5
1.3 1.4 1.4
1.5 1.2 1.3 1.3
1.1 1.2
1.1
1.0
0.5
0.0
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
3Q18
4Q18
1Q19
2Q19
3Q19
4Q19
1Q20
2Q20
3Q20
4Q20
1Q21
2Q21
3Q21
4Q21
3.0 2.9
2.5
2.0
2.0
1.7
1.4 1.5
1.5 1.4
1.2
1.0
0.5
0.0
FY16
FY17
FY18
FY19
FY20
FY21
YTD
Jun-20
Jul-20
Jan-21
Jun-21
Jul-21
Jan-22
Feb-20
Mar-20
Feb-21
Mar-21
Feb-22
Mar-22
Aug-20
Sep-20
Nov-20
Dec-20
Aug-21
Sep-21
Nov-21
Dec-21
Apr-20
May-20
Oct-20
Apr-21
May-21
Oct-21
ETFs as a Percent of Total Equity ADV
Single Stock ETF
100%
13.2%
14.3%
14.4%
15.4%
16.4%
16.8%
16.9%
17.5%
18.0%
18.2%
18.3%
18.5%
18.6%
19.6%
19.6%
20.0%
20.3%
20.4%
22.2%
23.5%
23.6%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
1Q17
2Q17
3Q17
4Q17
1Q18
2Q18
3Q18
4Q18
1Q19
2Q19
3Q19
4Q19
1Q20
2Q20
3Q20
4Q20
1Q21
2Q21
3Q21
4Q21
1Q22
Source: Bloomberg, Cboe Global Markets, SIFMA estimates
NYSE 21.4%
Cboe 17.4%
NASDAQ 17.2%
MEMX 5.2%
MIAX 1.8%
IEX 1.4%
LTSE 0.0008%
Blackrock 33.7%
Vanguard 29.1%
State Street
15.4%
Global Advisors
Invesco 5.6%
Other 12.4%
Cash Equities
Members
New York Stock Nasdaq Stock Exchange
Cboe BZX
Exchange Market
(MEMX)
Long-Term
NYSE Arca Nasdaq BX Cboe EDGX Stock Exchange
(LTSE)
NYSE American
Note: Another exchange was approved earlier this year, not yet in operation
Multi-Listed Options
Nasdaq MRX
Nasdaq BX
Order Types
AON All or none; an order to buy or sell a stock that must be executed in its entirety, or not executed at all
Block Trades with at least 10,000 shares in the order
Day Order is good only for that trading day, else cancelled
FOK Fill or kill; must be filled immediately and in its entirety or not at all
Limit An order to buy or sell a security at a specific price or better
Market An order to buy or sell a security immediately; guarantees execution but not the execution price
Stop (or stop-loss) An order to buy or sell a stock once the price of the stock reaches the specified price, known as the stop price
Investors
Institutional Organization, fewer protective regulations as assumed to be more knowledgeable and better able to protect themselves*
Retail Individual, a non-professional investor; either advised or self directed
*Types of institutional investors: asset managers, endowment funds, mutual funds, hedge funds, pension funds, etc.
IPO Initial Public Offering; private company raises capital buy offering its common stock to the public for the first time in the primary markets
SPAC Special Purpose Acquisition Company; blank check shell corporation designed to take companies public without going through the traditional IPO
process
Bought Deal underwriter purchases a company's entire IPO issue and resells it to the investing public; underwriter bears the entire risk of selling the stock
issue
Best Effort Deal Underwriter does not necessarily purchase IPO shares and only guarantees the issuer it will make a best effort attempt to sell the shares to
investors at the best price possible; issuer can be stuck with unsold shares
Secondary (Follow-on) Issuance of shares to investors by a public company already listed on an exchange
Direct Listing (Direct placement, direct public offering) Existing private company shareholders sell their shares directly to the public without underwriters. Often
used by startups or smaller companies as a lower cost alternative to a traditional IPO. Risks include, among others, no support/guarantee for the
share sale and no stock price stabilization after the share listing.
Underwriting Guarantee payment in case of damage or financial loss and accept the financial risk for liability arising from such guarantee in a financial
transaction or deal
Underwriter Investment bank administering the public issuance of securities; determines the initial offering price of the security, buys them from the issuer and
sells them to investors.
Bookrunner The main underwriter or lead manager in the deal, responsible for tracking interest in purchasing the IPO in order to help determine demand and
price (can have a joint bookrunner)
Lead Left Bookrunner Investment bank chosen by the issuer to lead the deal (identified on the offering document cover as the upper left hand bank listed)
Syndicate Investment banks underwriting and selling all or part of an IPO
Arranger The lead bank in the syndicate for a debt issuance deal
Pitch Sales presentation by an investment bank to the issuer, marketing the firm’s services and products to win the mandate
Mandate The issuing company selects the investment banks to underwrite its offering
Engagement Letter Agreement between the issuer and underwriters clarifying: terms, fees, responsibilities, expense reimbursement, confidentiality, indemnity, etc.
Letter of Intent Investment banks’ commitment to the issuer to underwrite the IPO
Underwriting Agreement Issued after the securities are priced, underwriters become contractually bound to purchase the issue from the issuer at a specific price
Registration Statement Split into the prospectus and private filings, or information for the SEC to review but not distributed to the public, it provides investors adequate
information to perform their own due diligence prior to investing
The Prospectus Public document issued to all investors listing: financial statements, management backgrounds, insider holdings, ongoing legal issues, IPO
information and the ticker to be used once listed
Red Herring Document An initial prospectus with company details, but not inclusive of the effective date of offering price
Roadshow Investment bankers take issuing companies to meet institutional investors to interest them in buying the security they are bringing to market.
Non-Deal Roadshow Research analysts and sales personnel take public companies to meet institutional investors to interest them in buying a stock or update existing
investors on the status of the business and current trends.
Pricing Underwriters and the issuer will determine the offer price, the price the shares will be sold to the public and the number of shares to be sold,
based on demand gauged during the road show and market factors
Stabilization Occurs for a short period of time after the IPO if order imbalances exist, i.e. the buy and sell orders do not match; underwriters will purchase
shares at the offering price or below to move the stock price and rectify the imbalance
Quiet Period (Cooling off period) The SEC mandates a quiet period on research recommendations, lasting 10 days (formerly 25 days) after the IPO
Reg S-K Regulation which prescribes reporting requirements for SEC filings for public companies
Reg S-X Regulation which lays out the specific form and content of financial reports, specifically the financial statements of public companies
Form S-1 Registration statement for U.S. companies (described above)
Form F-1 Registration statement for foreign issuers of certain securities, for which no other specialized form exists or is authorized
Form 10-Q Quarterly report on the financial condition and state of the business (discussion of risks, legal proceedings, etc.), mandated by the SEC
Form 10-K More detailed annual version of the 10Q, mandated by the SEC
Form 8-K Current report to announce major events shareholders should know about (changes to business & operations, financial statements, etc.)
Greenshoe Allows underwriters to sell more shares than originally planned by the company and then buy them back at the original IPO price if the demand
for the deal is higher than expected, i.e. an over-allotment option
Tombstone An announcement that securities are available for sale. (Also a plaque awarded to celebrate the completion of a transaction or deal)
EGC Emerging Growth Company
Authors
SIFMA Research
Katie Kolchin, CFA, Director of Research
Justyna Podziemska
research@sifma.org